Your browser doesn't support javascript.
loading
ß2-glycoprotein I promotes the clearance of circulating mitochondria.
Dasgupta, Swapan Kumar; Gollamudi, Jahnavi; Rivera, Stefanie; Poche, Ross A; Rumbaut, Rolando E; Thiagarajan, Perumal.
Affiliation
  • Dasgupta SK; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center and Departments of Pathology, Baylor College of Medicine, Houston, Texas, United States of America.
  • Gollamudi J; Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
  • Rivera S; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center and Departments of Pathology, Baylor College of Medicine, Houston, Texas, United States of America.
  • Poche RA; Department of Medicine Integrative Physiology, Baylor College of Medicine, Houston, Texas, United States of America.
  • Rumbaut RE; Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
  • Thiagarajan P; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center and Departments of Pathology, Baylor College of Medicine, Houston, Texas, United States of America.
PLoS One ; 19(1): e0293304, 2024.
Article de En | MEDLINE | ID: mdl-38271349
ABSTRACT
ß2-glycoprotein I (ß2-Gp1) is a cardiolipin-binding plasma glycoprotein. It is evolutionarily conserved from invertebrates, and cardiolipin-bound ß2-Gp1 is a major target of antiphospholipid antibodies seen in autoimmune disorders. Cardiolipin is almost exclusively present in mitochondria, and mitochondria are present in circulating blood. We show that ß2-Gp1 binds to cell-free mitochondria (CFM) in the circulation and promotes its phagocytosis by macrophages at physiological plasma concentrations. Exogenous CFM had a short circulation time of less than 10 minutes in mice. Following infusion of CFM, ß2-Gp1-deficient mice had significantly higher levels of transfused mitochondria at 5 minutes (9.9 ± 6.4 pg/ml versus 4.0 ± 2.3 pg/ml in wildtype, p = 0.01) and at 10 minutes (3.0 ± 3.6 pg/ml versus 1.0 ± 0.06 pg/ml in wild-type, p = 0.033, n = 10). In addition, the splenic macrophages had less phagocytosed CFM in ß2-Gp1-deficient mice (24.4 ± 2.72% versus 35.6 ± 3.5 in wild-type, p = 0.001, n = 5). A patient with abnormal ß2-Gp1, unable to bind cardiolipin, has increased CFM in blood (5.09 pg/ml versus 1.26 ± 1.35 in normal) and his plasma induced less phagocytosis of CFM by macrophages (47.3 ± 1.6% versus 54.3 ± 1.3, p = 0.01) compared to normal plasma. These results show the evolutionarily conserved ß2-Gp1 is one of the mediators of the clearance of CFM in circulation.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cardiolipides / Syndrome des anticorps antiphospholipides Limites: Animals / Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cardiolipides / Syndrome des anticorps antiphospholipides Limites: Animals / Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique